Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moschetta

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Scientific Reports|February 10, 2025
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgeryL I Sgaramella, A Pasculli, M Moschetta, et al.
Leukemia|October 25, 2016
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaS Manier, J T Powers, A Sacco, et al.
Leukemia|September 3, 2013
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studiesM A Frassanito, L Rao, M Moschetta, et al.
Oncogene|October 4, 2011
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targetsS Berardi, A Caivano, R Ria, et al.
Leukemia|March 28, 2017
Proteomic characterization of human multiple myeloma bone marrow extracellular matrixS V Glavey, A Naba, S Manier, et al.
Leukemia|February 10, 2016
Targeting vasculogenesis to prevent progression in multiple myelomaM Moschetta, Y Mishima, Y Kawano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-populationN C Turner, E Alarcón, A C Armstrong, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Scientific Reports|February 10, 2025
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgeryL I Sgaramella, A Pasculli, M Moschetta, et al.
Leukemia|October 25, 2016
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaS Manier, J T Powers, A Sacco, et al.
Leukemia|September 3, 2013
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studiesM A Frassanito, L Rao, M Moschetta, et al.
Oncogene|October 4, 2011
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targetsS Berardi, A Caivano, R Ria, et al.
Leukemia|March 28, 2017
Proteomic characterization of human multiple myeloma bone marrow extracellular matrixS V Glavey, A Naba, S Manier, et al.
Leukemia|February 10, 2016
Targeting vasculogenesis to prevent progression in multiple myelomaM Moschetta, Y Mishima, Y Kawano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-populationN C Turner, E Alarcón, A C Armstrong, et al.
Pageof 5